This Month in Psychopharmacology

FDA Approves First Test to Help Identify Risk of Opioid Use Disorder

The U.S. Food and Drug Administration approved the first genetic te...

Read More

Risk of Progression From Mild or Moderate to Severe Alcohol Use Disorder

Predicting the development of severe alcohol use disorder is diffic...

Read More

Substance-Induced Psychosis Tied to Schizophrenia Risk

individuals without a history of psychosis were assessed for the li...

Read More

AAFP Updates Alcohol Use Practice Manual

The AAFP has recently published an updated practice manual on addre...

Read More

Genetic Link Between Eating Disorders and Alcohol Use

Previous research has shown a connection between eating disorders a...

Read More

Integrating Opioid Use Disorder Treatment Into Primary Care Settings

Opioid use disorder (OUD) is undertreated even though there are eff...

Read More

Injection Drug Use Frequency Before and After Take-Home Naloxone Training

Naloxone, a medication designed to quickly reverse opioid overdose,...

Read More

FDA Issues Draft Guidance on Psychedelic Drug Trials

While there is still much to learn about the potential therapeutic ...

Read More

Psychedelics and PTSD

At this moment, of the two drugs, MDMA-assisted psychotherapy has s...

Read More

Stimulant Treatment in Youth Not Associated With Substance Use Later in Life

Childhood attention-deficit/hyperactivity disorder (ADHD) is linked...

Read More

Patterns in Nicotine Dependence Prevalence

Smoking remains a leading global cause of preventable death and dis...

Read More

New Guidelines for Cannabis in Chronic Pain Management Released

In this timely study, researchers performed a systematic review of ...

Read More